CCRM in the News 2019

A sampling of media coverage that profiles or mentions CCRM

Measure Twice, Treat Once: Navigating the Regulatory Landscape of Assay Development to Ensure High-Quality CGT Products. BioProcess International, December 16, 2019.

Medicine by Design draws hundreds to annual research event, praise by federal innovation minister. U of T News, December 9, 2019.

Biotech ecosystems aim to start the talent pipeline early in a student’s career. The Globe and Mail, November 14, 2019.

The Innovations Arms Race: Commercializing Life Sciences in Toronto. Life Sciences Career Development Society website. November 11, 2019.

NGen Manufacturing Program Supports $4.2M Project. Mentor Works, November 6, 2019.

Allogene sets sights on iPS cell-based allogeneic therapies via Notch partnership. BioCentury, November 5, 2019.

Allogene, Notch partner to develop iPSC-derived blood cancer therapies. Genetic Engineering & Biotechnology News, November 5, 2019.

Forward thinking – evolving the cell and gene therapy industry: Modern CAR T-cell process addresses future demand. BioProcess International, October 28, 2019.

Special report on cell biology: Making bioprogress. DDNews, October 5, 2019.

Out of order: Check your ego. DDNews, September 2019.

Ontario continues to establish its role as a world leader in regenerative medicine. Clinical Trials Ontario website, September 12, 2019.

Special report on stem cells: Hope over hype. DDNews, September 10, 2019.

NGen Contributes to C$4.2m Canadian viral vector manufacturing project. Manufacturing Chemist, September 10, 2019.

Advanced Manufacturing Supercluster project kicks off with NGen funding. Canadian Manufacturing, August 22, 2019.

Advanced manufacturing supercluster invests in potentially life-saving gene therapies. U of T News, August 22, 2019.

Ontario’s Advanced Manufacturing Supercluster Announces First Project. BetaKit, August 21, 2019.

Big Red Oak honoured with 2019 video awards. Big Red Oak, August 7, 2019.

Gene-Editing Techniques Target New Applications. BioPharm International, August 1, 2019.

Designing production facilities of the future. BioPharma-Asia, July 30, 2019.

Process development of a closed CAR-T manufacturing process. BioProcess International, July 18, 2019.

These startups want to freeze your cells.  Medium’s Elemental, June 27, 2019.

Innovative Solutions from Industry 4.0. (Webinar) BioPharma-Asia, June, 10, 2019.

CCRM & the new CCVP facility: an interview with Director of Operations, Helen Pejnovich, P.EngSociety Notes, June 5, 2019.

Ontario companies fill marketplace voids. Biotechnology Focus, June 3, 2019.

Cell Therapy Manufacturing Under GMP – How And When To Get Started. Cell & Gene, May 2, 2019.

Are we moving towards a more automated CAR-T cell manufacturing process? RegMedNet, April 30, 2019.

Collaboration will drive regenerative medicine: Toronto development center will help to advance the field. BioProcess International, April 18, 2019.

Study reveals large molecular differences between stem cells grown on different biomaterials. Donnelly Centre website. April 15, 2019.

Michael May discusses the intersection of medical devices in regenerative medicine. StarFish Medical, Mar. 20, 2019.

GE Healthcare looks to spawn growth in regenerative medicine with CCRM partnership. Genetic Engineering & Biotechnology News, Jan. 31, 2019.

Federal government to defund Networks of Centres of Excellence. The Varsity, Jan. 29, 2019.

General Electric: The immunotherapy hurdle – and why doctors could soon predict how each patient will respond. Market Screener, Jan. 6, 2019.

Navigating the regulatory complexity of Regenerative Medicine in Canada. Biotechnology Focus, December 2018/January 2019 issue.

News pages contact

If you are a member of the media, please contact stacey.johnson@ccrm.ca.
Font Resize
Enable Contrast